hemotune featured by BILANZ

In an interview in the current issue of BILANZ Wirtschaftsmagazin 08/2021 our CEO Lukas Langenegger gives insights into the various facets of our cutting edge development at hemotune and why there is an urgent need for sepsis treatments. He points out the importance of how investing into translating academic research brings real-world products to market and maintains the Switzerland's competitiveness.

Access the full interview and many other impressive innovation stories:

hemotune Bilanz

.pdf

Download PDF • 294KB